Antipsychotic toxicity: Difference between revisions

(Text replacement - "Category:Tox" to "Category:Toxicology")
(Added workup items.)
Line 25: Line 25:
{{Anticholinergic types}}
{{Anticholinergic types}}


==Diagnosis==
==Workup==
* POC Glucose
* ECG (QT interval)
* Co-ingestions: serum acetaminophen, salicylate, EtOH level, other known drug levels
* Urine toxicology screen
* Chemistry (metabolic acidosis, electrolytes, renal function)
* LFT (hepatotoxicity)
* CK (rhabdomyolysis)
* Serum osmolarity (osmolar gap)
* ABG (carboxyhemoglobin, methemoglobin)


==Treatment==
==Treatment==

Revision as of 21:03, 3 June 2016

Background

  • Isolated overdose of antipsychotics is rarely fatal
  • Toxicity results in blockade of some or all of the following receptors:
    • Dopamine - extrapyramidal symptoms
    • Alpha-1 - orthostatic hypotension, reflex tachycardia
    • Muscarinic - anticholinergic symptoms
    • Histamine - sedation

Clinical Features

Evaluation of SGA (Second Generation Antipsychotic) Toxicity
  • Extrapyramidal
    • Acute dystonia
      • Tongue protrusion, facial grimacing, trismus, oculogyric crisis
    • Akathisia
  • CNS
    • Lethargy, ataxia, dyarthria, confusion, coma
    • Seizure (1%)
  • Anticholinergic Effects
    • Tachycardia, dry mucous membranes, dry skin, decreased bowel sounds, delirium
  • ECG changes
    • Sinus tachycardia
    • QT prolongation

Differential Diagnosis

Anticholinergic toxicity Causes

Workup

  • POC Glucose
  • ECG (QT interval)
  • Co-ingestions: serum acetaminophen, salicylate, EtOH level, other known drug levels
  • Urine toxicology screen
  • Chemistry (metabolic acidosis, electrolytes, renal function)
  • LFT (hepatotoxicity)
  • CK (rhabdomyolysis)
  • Serum osmolarity (osmolar gap)
  • ABG (carboxyhemoglobin, methemoglobin)

Treatment

Disposition

  • Consider discharge after 6hr as long as there are all of the following:
    • No mental status changes
    • Normal HR/BP
    • No orthostatic hypotension
    • Normal QT interval

See Also

References

  1. Dawson AH, Buckley NA. Pharmacological management of anticholinergic delirium – theory, evidence and practice. Br J Clin Pharmacol. 2015;81(3):516-24.